Skip to main content
    C

    Chiron Real Estate Inc. (XRN)

    Official site

    REAL ESTATE • NYSE

    $28.75
    -0.96 (-3.23%)

    Market Cap: $430.20M

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    24%(7/29)
    Avg Surprise
    -73.64%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$4.32
    Range$3.94 - $4.89
    3 analysts
    Revenue Consensus
    $39M
    Range$32M - $44M
    7 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$4.32$3.94 - $4.89--3--
    Sep 26
    Reported Nov 4
    		$0.75$0.55$0.40 - $0.83+36.36%Beat3
    0
    1
    30d
    		+7400.0%
    Jun 26
    Reported Aug 5
    		$0.88$0.83$0.83 - $0.83+6.02%Beat1
    0
    1
    30d
    		+1200.0%
    Mar 26
    Reported May 6
    		$-0.06$0.01$0.00 - $0.01-1300.00%Miss2
    No revisions (30d)
    		-220.0%
    Dec 25
    Reported Feb 25
    		$-0.02N/A--115.38%Miss1
    No revisions (30d)
    		+90.0%
    Sep 25
    Reported Nov 4
    		$0.01N/A--80.00%Miss---93.3%
    Jun 25
    Reported Aug 5
    		$-0.08$0.05--260.00%Miss---500.0%
    Mar 25
    Reported May 7
    		$0.05$0.08--37.50%Miss--+0.0%
    Dec 24
    Reported Feb 28
    		$-0.20$0.00-N/AMiss---212.0%
    Sep 24
    Reported Nov 6
    		$0.15$0.12-+25.00%Beat--+150.0%
    Jun 24
    Reported Aug 6
    		$0.02$-0.02-+200.00%Beat--+128.6%
    Mar 24
    Reported May 7
    		$0.05$0.05-+0.00%Beat--+150.0%
    Dec 23
    Reported Feb 28
    		$-0.06N/A-N/ABeat---327.3%

    Dividends

    Next ex-dividend: Nov 20, 2026

    Dividend Metrics

    Forward Yield6.68%
    Forward Annual Dividend$1.92
    Payout Ratio27.32%
    FrequencyMonthly
    Pay MonthsJan, Apr, May, Jun, Jul, Aug, Sep, Oct, Nov, Dec

    Growth

    3Y CAGR-15.32%
    5Y CAGR-8.61%
    XRN dividend history and ex-dividend datesRun XRN in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio18.55EV/EBITDA2.32x
    Price/FCF-2.03xFCF Yield-49.29%
    Profitability
    Profit Margin37.80%Operating Margin23.20%
    ROE10.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage3.01x
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta1.13Avg Volume211.66K
    52-Week High$37.9452-Week Low$28.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$29.93
    SMA 20$30.31
    SMA 50$33.38
    SMA 200$34.51
    EMA 10$30.06
    EMA 20$30.72
    EMA 50$32.52
    EMA 200$33.98

    MACD

    Line: -0.99Signal: -1.14Hist: 0.15

    ADX

    ADX: 44.3+DI: 15.4-DI: 31.8

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down72.0
    PSAR$31.68

    Bollinger Bands

    Upper Band$32.73
    Lower Band$27.88
    %B Position1601%(Upper)
    Band Width0.18

    RSI (14-Day)

    Neutral
    36.3

    Momentum Oscillators

    Stoch %K53.2
    Stoch %D63.8
    Williams %R-81.9
    ROC (10d)-4.2%
    Momentum-1.25
    CCI (20d)-92.4
    MFI (14d)52.5

    Volatility Measures

    ATR (14d)$1.11(3.9%)
    StdDev (20d)1.21
    Hist Vol48.7%(High)

    Volume Flow

    VWAP$29.11
    OBV-4.4M
    AD Line19.4B
    CMF (20d)-0.198

    Volume Metrics

    Avg Vol (20d)223.9K
    Vol Ratio0.8x
    VWMA (20d)$30.14

    Pivot Points

    R3$34.04
    R2$32.84
    R1$31.27
    Pivot Point$30.07
    S1$28.50
    S2$27.30
    S3$25.73

    Advanced Oscillators

    TSI-24.93
    Ultimate Osc48.7
    KST-123.99

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$40.34M$39.75M$38.06M$38.39M$40.56M$41.27M$37.88M$34.95M$34.17M$34.21M$35.07M$32.93M
    Cost of RevenueN/A$40.59M$38.90M$38.43M$38.24M$38.80M$35.24M$7.20M$7.44M$7.24M$7.38M$6.09M
    Gross ProfitN/A$-839,000$-840,000$-35,000$2.32M$2.47M$2.64M$27.76M$26.74M$26.98M$27.68M$26.84M
    Operating Expenses$14.13M$-10,055,000$-9,738,000$-9,423,000$-10,148,000$-9,266,000$-10,207,000$21.35M$18.02M$18.58M$18.53M$18.46M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$7.70M$5.22M$5.09M$5.49M$4.86M$5.46M$3.52M$7.71M$4.38M$4.59M$4.45M$4.22M
    Operating IncomeN/A$9.22M$8.90M$9.39M$12.47M$11.74M$12.85M$6.41M$8.71M$8.40M$9.15M$8.37M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$8.31M$8.81M$7.23M$8.40M$11.51M$11.31M$10.43M$7.57M$7.24M$6.99M$6.89M$6.98M
    Income Before Tax$-8,863,000$72.28M$1.65M$-6,147,000$-5,058,000$585,000$3.74M$2.94M$3.39M$-1,952,000$2.31M$551,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-8,863,000$66.27M$1.72M$-5,504,000$-4,546,000$655,000$3.56M$2.83M$3.25M$-1,692,000$2.25M$616,000
    EBITDAN/A$96.19M$23.71M$17.17M$21.31M$26.90M$28.21M$24.40M$24.45M$19.18M$23.43M$21.95M
    EBITN/A$81.09M$8.89M$2.26M$6.45M$11.89M$14.17M$10.51M$10.63M$5.04M$9.20M$7.54M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XRN

    News

    Global Medical REIT (NYSE:XRN) Coverage Initiated by Analysts at Huntington

    Huntington has initiated coverage on Global Medical REIT (NYSE:XRN) with a "hold" rating, contributing to a consensus "hold" rating and an average price target of $40.17 for the stock. Shares traded down 5.5% at market...

    MarketBeat•11/6/26•Somewhat-Bearish

    Global Medical REIT Q3 2026 Earnings Results and Report

    Global Medical REIT (XRN) missed analyst earnings expectations for Q3 2026, reporting an EPS of -$0.67 against a $0.55 consensus, with revenue at $40.34 million. The company is in a significant transition...

    MarketBeat•11/5/26•Bearish

    Global Medical REIT Inc. (NYSE:XRN) Stock Now Rated "Hold" by Wall Street Analysts

    Nine Wall Street analysts currently rate Global Medical REIT Inc. (NYSE:XRN) as "Hold," with an average 12-month price target of $40.17...

    MarketBeat•10/13/26•Somewhat-Bullish

    Global Medical REIT (NYSE:XRN) Stock Gets Downgrade from Wall Street Zen

    Wall Street Zen downgraded Global Medical REIT (NYSE:XRN) from "hold" to "sell," while other analysts maintain a more positive outlook with a consensus "Hold" rating and a $40.17 target price. The stock opened at $33.64...

    MarketBeat•10/10/26•Somewhat-Bearish

    3UN0.SG Interactive Stock Chart | Global Medical REIT Inc. Stock

    This page provides an interactive stock chart for Global Medical REIT Inc. (3UN0.SG) on the Stuttgart exchange. The current delayed quote shows the stock at EUR 30.00...

    Yahoo Finance•10/2/26•Neutral

    XRN Valuation and Fair Value

    P/E
    18.5x
    Forward P/E
    625.0x
    EV/EBITDA
    2.3x
    P/FCF
    -2.0x
    PEG
    5.1x
    P/B
    0.6x
    See GNG's fair value

    XRN Profitability: Margins, ROIC and FCF

    Operating margin
    23.2%
    Net margin
    37.8%
    ROE
    10.4%
    FCF margin
    -119.9%
    FCF yield
    -49.3%

    XRN Competitors

    CompanyTicker
    Brightspire Capital IncBRSP
    Community Healthcare Trust IncCHCT
    Transcontinental Realty InvestorsTCI
    Gladstone Land CorpLANDM
    One Liberty Properties IncOLP
    Industrial Logistics Properties TrustILPT
    Franklin BSP Realty Trust IncFBRT
    Farmland Partners IncFPI

    Sector: Real Estate

    XRN Analyst Ratings

    Consensus
    Buy
    Analysts
    11
    Strong Buy
    2
    Buy
    3
    Hold
    6
    Sell
    0
    Strong Sell
    0

    XRN Bull Case vs Bear Case

    Bull case

    • XRN has a 37.8% net profit margin.

    Bear case

    • XRN beat EPS estimates in 25.0% of its last 8 reported quarters.

    XRN Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -250.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $4.32

    XRN Dividend

    Forward yield
    6.7%
    Payout ratio
    27.3%
    3Y DPS growth
    -15.3%
    5Y DPS growth
    -8.6%
    Pay months
    Jan, Apr, May, Jun, Jul, Aug, Sep, Oct, Nov, Dec
    XRN dividend history

    XRN Earnings Date

    XRN reports Feb 23, 2027, after the close. The date is estimated.

    XRN Earnings Call

    The latest XRN earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    XRN ETF Holders

    GNG tracks 4 ETFs that hold XRN. The largest weights:

    1. Fidelity Enhanced Small Cap Core ETF (FESM), 0.04% of the fund
    2. Schwab U.S. REIT ETF (SCHH), 0.03% of the fund
    3. Vanguard Real Estate Index Fund ETF Shares (VNQ), 0.02% of the fund
    4. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    Open the ETF Stock Exposure tool for XRN

    Frequently Asked Questions About XRN

    When is XRN's next ex-dividend date?

    XRN's next ex-dividend date is Nov 20, 2026, for a declared dividend of $0.16 per share (record date Nov 20, 2026, payable Dec 18, 2026).

    When does XRN report earnings?

    Chiron Real Estate Inc. (XRN) is expected to report earnings on Feb 23, 2027.

    What is XRN's current dividend yield?

    Chiron Real Estate Inc. (XRN) has a forward dividend yield of 6.68%.

    Does XRN pay dividends?

    Yes, Chiron Real Estate Inc. pays dividends with a forward dividend yield of 6.68%.

    What is XRN's P/E ratio?

    Chiron Real Estate Inc. has a price-to-earnings (P/E) ratio of 18.55.

    Related stocks

    Sector: Real Estate

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In